I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 2.11 USD Market Closed
Market Cap: 62.6m USD
Have any thoughts about
Immuneering Corp?
Write Note

Wall Street
Price Targets

IMRX Price Targets Summary
Immuneering Corp

Wall Street analysts forecast IMRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMRX is 11.44 USD with a low forecast of 1.52 USD and a high forecast of 26.25 USD.

Lowest
Price Target
1.52 USD
28% Downside
Average
Price Target
11.44 USD
442% Upside
Highest
Price Target
26.25 USD
1 144% Upside

IMRX Last Price Targets
Immuneering Corp

The latest public price target was made on Apr 2, 2024 by Graig Suvannavejh from Mizuho Securities , who expects IMRX stock to rise by 279% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Graig Suvannavejh
Mizuho Securities
8 USD
Upside 279%
7 months ago
Apr 2, 2024
Immuneering Corporation (IMRX) PT Lowered to $8 at Mizuho, 'maintain our favorable view on IMRX's innovative approach'
StreetInsider
Michael Yee
Jefferies
3 USD
Upside 42%
8 months ago
Mar 15, 2024
Jefferies Downgrades Immuneering Corporation (IMRX) to Hold
StreetInsider
Graig Suvannavejh
Mizuho Securities
Price Target 8 USD
Upside/Downside 279%
View Source
Michael Yee
Jefferies
Price Target 3 USD
Upside/Downside 42%
View Source
Immuneering Corp Competitors:
Price Targets
4893
Noile-Immune Biotech Inc
159% Upside
AURA
Aura Biosciences Inc
153% Upside
XOMA
XOMA Corp
192% Upside
IMAB
I-Mab
646% Upside
BIIB
Biogen Inc
60% Upside
VRDN
Viridian Therapeutics Inc
108% Upside
TNGX
Tango Therapeutics Inc
200% Upside
CCCC
C4 Therapeutics Inc
311% Upside

Revenue
Forecast

Revenue Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMRX's stock price target?
Price Target
11.44 USD

According to Wall Street analysts, the average 1-year price target for IMRX is 11.44 USD with a low forecast of 1.52 USD and a high forecast of 26.25 USD.

Back to Top